Ceftriaxone & Tazobactam Injection 1.125 Gm – Cefazid TZ 1.125 Injection

Cefazid TZ 1.125 Injection
Composition:- Ceftazidime 1gm + Tazobactam 125 mg

Cefazid TZ 1.125 Injection – The composition ceftriaxone & tazobactam 1.125gm Injection belongs to a class of medication called cephalosporin antibiotics. It is used to treat various bacterial infections in the body. A bacterial infection is a condition in which harmful bacteria grow in the body and cause infection and contains Ceftazidime and Tazobactam. Ceftazidime works by interfering with the formation of the bacterial cell wall (a protective covering) that is necessary for their survival. Tazobactam decreases bacterial resistance and enhances the activity of Ceftazidime against the bacteria. Together, Ceftazidime+tazobactam helps to treat bacterial infections.

Key Points of Ceftazidime 1gm + Tazobactam 125 mg Injection – Cefazid TZ 1.125 Injection

• Synergistic Combination for Maximum Efficacy: combination of Ceftazidime (a broad-spectrum cephalosporin) and Tazobactam (a beta-lactamase inhibitor) enhances antibacterial activity, making it effective against a wide range of gram-negative, gram-positive, and anaerobic bacteria, including resistant pathogens like Pseudomonas aeruginosa.
• Parenteral Administration for Rapid Action: Administered intravenously ffers rapid onset of action and high bioavailability, ensuring that patients, especially in critical care environments, receive immediate therapeutic effects.
• Low Risk of Cross-Resistance: Ceftazidime has a low risk of cross-resistance with other commonly used antibiotics, making it a reliable option in the treatment of resistant infections.

Can be Prescribed by:

• Infectious Disease Specialists
• Surgeons (General, GI, and other specialties)
• Healthcare practitioner

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.